The $1 million payout to a Danish security expert is believed to be the first in a cybersecurity case brought under the False Claims Act.
The maker of the fentanyl spray Subsys "is being held responsible for its role in fueling the opioid epidemic," a prosecutor says.
The case arose from a whistleblower who alleged Kmart was overcharging Medicare customers for generic drugs.
The medical device maker was accused of paying bribes and kickbacks to doctors and hospital administrators to win new business.
The whistleblower suit alleged Moody's issued false credit ratings on complex securities, costing the U.S. government billions.
Patients "are entitled to receive care that is dictated by their clinical needs rather than the fiscal interests of healthcare providers," said the DoJ.
The Swiss drug maker allegedly turned specialty pharmacies into a "biased sales force" for its medications.
The Cincinnati bank was accused of waiting too long to report that more than 1,400 mortgage loans were defective, resulting in federal insurance losses.
To ramp up successful prosecutions of Wall Street wrongdoers, the U.S. Attorney General is proposing larger financial rewards for whistleblowers.
